Sidal begins production of insulin intended for hospital use – Al-Hiwar Algeria

And the Director of Pharmaceutical Production, Nadia Bouabdallah, representing the Minister of Industry and Pharmaceutical Production, Ali Aoun, supervised today in the Constantine 1 production unit of the “Sidal” complex, the launch of insulin production in the form of a vial destined for hospitals, with a complete production pattern, and a total capacity of more than 4 million vials. In her intervention, the Director of Pharmaceutical Production confirmed that thanks to this achievement, the Saidal complex and the pharmaceutical industry in Algeria in general are achieving a real leap, which enshrines the concept of health and pharmaceutical sovereignty, which falls within the framework of the public authorities’ endeavor to improve health care for patients, by ensuring the availability of this drug The primary, which was hostage to import, although the Sidal complex had previously produced it in 2006.

Nadia Bouabdallah also stated that the production of this drug locally is not a return to the basics and principles upon which the Saidal complex was built, pursuant to the directives of Minister Ali Aoun, who instructed Director General Fattoum Akassem to return to insulin production in the Constantine 2 unit, as an embodiment of the desire of the President of the Republic Abdel Majeed. Tebboune is in the process of restoring the “Saidal” complex to its position as a locomotive in the Algerian market.